According to the median, Kaplan-Meier curve indicates a significantly worse DFS for patients with CDK7 high expression in NSCLC than for patients with CDK7 low expression in NSCLC (log-rank test p 0.022; Figure 5A). This evidence concerns the gene CDK7 and non-small cell lung carcinoma.